Table 1 Relationship between the clinicopathological variables and TMEM43 expression in pancreatic cancer
From: TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis
Parameters | Total (n) | TMEM43 expression | ||
|---|---|---|---|---|
Low expression | High expression | p-Value | ||
Gender | ||||
Male | 36 | 9 | 27 | |
Female | 28 | 7 | 21 | 1.00 |
Age(years) | ||||
< 60 | 21 | 5 | 16 | |
≥ 60 | 43 | 11 | 32 | 0.878 |
T stage | ||||
T 1–2 | 13 | 6 | 7 | |
T 3–4 | 47 | 9 | 38 | 0.047* |
N stage | ||||
N 0 | 37 | 12 | 25 | |
N 1–2 | 23 | 3 | 20 | 0.0919 |